Category

Cohort News

New Research Validating VeraBIND™ Tau Assay as Accurate Blood Test for Active Tau Pathology in Alzheimer’s Disease Presented at the 2025 Alzheimer’s Association International Conference featuring Veravas Inc.

//
Categories
Developed by Veravas Inc., VeraBIND™ Tau Assay is the first blood-based test that measures pathologically active tau for the early detection of Alzheimer’s disease in both asymptomatic and symptomatic individuals AUSTIN, Texas, July 28, 2025 /PRNewswire/ — Veravas Inc., an...
Read More →